These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11263053)

  • 1. [Photodynamic therapy: Recommendations for indication and treatment].
    Schmidt-Erfurth U; Laqua H
    Ophthalmologe; 2001 Feb; 98(2):216-9; quiz 230. PubMed ID: 11263053
    [No Abstract]   [Full Text] [Related]  

  • 2. [Photodynamic therapy. Foreword ].
    Pournaras CJ
    J Fr Ophtalmol; 2004 Jan; 27(1):72-4. PubMed ID: 14968082
    [No Abstract]   [Full Text] [Related]  

  • 3. Are the submacular surgery trials still relevant in an era of photodynamic therapy?
    Bressler NM; Hawkins BS; Sternberg P; McDonald HR
    Ophthalmology; 2001 Mar; 108(3):435-6. PubMed ID: 11237895
    [No Abstract]   [Full Text] [Related]  

  • 4. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
    Verteporfin In Photodynamic Therapy Study Group
    Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.
    Parodi MB; Da Pozzo S; Ravalico G
    Br J Ophthalmol; 2003 Feb; 87(2):177-83. PubMed ID: 12543747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.
    Bressler NM
    Am J Ophthalmol; 2002 Jan; 133(1):168-9. PubMed ID: 11755871
    [No Abstract]   [Full Text] [Related]  

  • 11. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.
    Gelisken F; Inhoffen W; Partsch M; Schneider U; Kreissig I
    Am J Ophthalmol; 2001 Apr; 131(4):518-20. PubMed ID: 11292425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visudyne photodynamic therapy and feeder vessel occlusion: rationale of a synergistic association and clinical options].
    Sickenberg M; Ballini JP; van den Bergh H
    J Fr Ophtalmol; 2004 Jan; 27(1):93-102. PubMed ID: 14968086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Isola V; Pece A; Brancato R
    Retina; 2004 Aug; 24(4):618-20. PubMed ID: 15300088
    [No Abstract]   [Full Text] [Related]  

  • 14. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
    Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
    Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.
    Soubrane G; Bressler NM
    Br J Ophthalmol; 2001 Apr; 85(4):483-95. PubMed ID: 11264143
    [No Abstract]   [Full Text] [Related]  

  • 16. [Photodynamic therapy carefully destroys neovascularization of the retina].
    Ophthalmologe; 2003 Feb; 100(2):1 p following 174. PubMed ID: 12650171
    [No Abstract]   [Full Text] [Related]  

  • 17. Photodynamic therapy with verteporfin: a new treatment in ophthalmology.
    Michels S; Schmidt-Erfurth U
    Semin Ophthalmol; 2001 Dec; 16(4):201-6. PubMed ID: 15513441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.
    ; ;
    Retina; 2002 Feb; 22(1):6-18. PubMed ID: 11884872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring the patient after treatment: angiographic aspects of recurrence and indications for retreatment].
    Coscas G; Coscas F; Soubrane G
    J Fr Ophtalmol; 2004 Jan; 27(1):81-92. PubMed ID: 14968085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration.
    Fine SL
    Arch Ophthalmol; 1999 Oct; 117(10):1400-2. PubMed ID: 10532450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.